Skip to main content

Day: July 9, 2024

Spectrum Group International Announces Results of Cash Election Merger

COSTA MESA, Calif., July 09, 2024 (GLOBE NEWSWIRE) — Spectrum Group International, Inc. (SPGZ) (the “Company”), an integrated network of leading companies concentrating on numismatics (coins) and paper currency, announced the results of its cash election merger, in which certain eligible shareholders could elect to receive either cash consideration or shares in a new holding company.   As a result of the merger, the Company became a wholly-owned subsidiary of the holding company, which is being renamed Spectrum Group International, Inc. (“New SGI”) The merger was consummated on July 9, 2024 by filing of a certificate of merger with the Secretary of State of Delaware. Prior to the merger, there were 2,035 shares of common stock of the Company outstanding. In connection with the merger, eligible holders of 1,865 shares of common...

Continue reading

Dundee Corporation Obtains Additional C$5 Million Under Amended and Restated Term Loan Facility

TORONTO, July 09, 2024 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A, DC.PR.B and DC.PR.D) (“Dundee” or the “Corporation”) announced today that it has entered into an amended and restated loan agreement dated July 9, 2024 (the “Amended and Restated Loan Agreement”) among the Corporation, as borrower, Dundee Resources Limited, as guarantor, and Earlston Investments Corp. (“Earlston”), as lender, pursuant to which Earlston has agreed to advance an additional C$5,000,000 to Dundee (the “Second Advance”). The Second Advance was advanced by Earlston to Dundee on July 9, 2024. Outstanding obligations under the Amended and Restated Loan Agreement are guaranteed by Dundee Resources Limited and secured by a security interest over all present and after-acquired personal property of the Corporation and Dundee Resources Limited, including...

Continue reading

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age

ZORYVE cream provides rapid relief, with efficacy, safety, and tolerability demonstrated up to 56 weeks of treatment ZORYVE cream rapidly and significantly reduces itch, the most bothersome symptom of atopic dermatitis (AD) Once-daily cream is for use anywhere on the body for any duration AD is the most common type of eczema, affecting approximately 9.6 million children and 16.5 million adults in the United States Third FDA approval for Company in two years Commercial product expected to be available by the end of JulyWESTLAKE VILLAGE, Calif., July 09, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental new...

Continue reading

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio

Combined organization brings broader predictive capabilities to drug discovery at scale Reiterates full year 2024 guidance RADNOR, Pa., July 09, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced it has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software. The transaction is expected to close in the second half of 2024, subject to regulatory approval and other customary closing conditions. Chemaxon develops leading software products for chemical structure drawing, property prediction, search, and analysis. Used by research scientists globally, Chemaxon software helps to digitize the design, make, test and analyze (DMTA) lifecycle to discover the best new chemical leads. Certara and Chemaxon have had a long-term partnership...

Continue reading

ChampionX Acquires RMSpumptools, Expanding Global Presence in Offshore Production Technologies Markets

THE WOODLANDS, Texas, July 09, 2024 (GLOBE NEWSWIRE) — ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ: CHX), a global leader in oilfield technology, announced today it has completed the acquisition of RMSpumptools Limited, a designer and manufacturer of highly engineered mechanical and electrical solutions for complex artificial lift applications. “By adding RMSpumptools technology to our Production & Automation Technologies (“PAT”) portfolio, ChampionX advances its ability to deliver greater value to customers while creating growth opportunities in international markets such as the Middle East, Latin America, and global offshore projects,” said Sivasankaran “Soma” Somasundaram, President and CEO of ChampionX. “RMSpumptools’ comprehensive range of products and services complement and integrate seamlessly...

Continue reading

James River Announces Director Appointment

PEMBROKE, Bermuda, July 09, 2024 (GLOBE NEWSWIRE) — James River Group Holdings, Ltd. (“James River” or the “Company”) (NASDAQ: JRVR) today announced that Christine LaSala has been appointed to its Board of Directors (the “Board”) as an independent, non-executive member, effective immediately. With the appointment of Ms. LaSala, the Board has increased its size from seven to eight directors. Ms. LaSala was appointed to the Compensation and Human Capital Committee and the Nominating and Corporate Governance Committee. “I am thrilled to welcome Christine to our Board,” said Frank D’Orazio, the Company’s Chief Executive Officer. “She has deep knowledge of the specialty property and casualty insurance industry and extremely valuable corporate governance expertise.” Chairman Ollie L. Sherman, Jr., added, “We are fortunate to be adding...

Continue reading

James River Announces Legacy Reinsurance Agreement with State National Insurance Company

PEMBROKE, Bermuda, July 09, 2024 (GLOBE NEWSWIRE) — James River Group Holdings, Ltd. (“James River” or the “Company”) (NASDAQ: JRVR) today announced that two of its principal operating subsidiaries entered into a combined loss portfolio transfer and adverse development cover reinsurance agreement with State National Insurance Company, Inc. (“State National”). Under the terms of the agreement, State National will provide $160.0 million of adverse development reinsurance coverage for James River’s Excess and Surplus Lines segment casualty portfolio for accident years 2010-2023 (both years inclusive), subject to a 15% co-participation by the Company. The reinsurance structure has no coverage sublimits but does exclude exposure to the Company’s former large commercial auto insured, with the vast majority of that exposure already subject...

Continue reading

Crown LNG Holding AS Announces Completion of Business Combination with Catcha Investment Corp

 Combination accelerates Crown LNG’s mission to enable stable, secure, year-round LNG supplies to growing markets and locations exposed to harsh weather conditions.  Crown LNG Holdings Limited shares and warrants to begin trading on the Nasdaq on July 9, 2024 under ticker “CGBS” and “CGBSW,” respectively.OSLO, NORWAY, July 09, 2024 (GLOBE NEWSWIRE) — Crown LNG Holding AS (“Crown” or “Crown LNG”), a leading provider of LNG liquefaction and regasification terminal technologies for harsh weather locations, today announced that it has completed its previously announced business combination (the “Business Combination”) with Catcha Investment Corp (“Catcha”). The transaction was unanimously approved by Catcha’s board of directors and was approved at an extraordinary general meeting of Catcha shareholders on June 12, 2024. The combined...

Continue reading

XPO Schedules Second Quarter 2024 Earnings Conference Call for Thursday, August 1, 2024

GREENWICH, Conn., July 09, 2024 (GLOBE NEWSWIRE) — XPO (NYSE: XPO) will hold its second quarter conference call and webcast on Thursday, August 1, at 8:30 a.m. Eastern Time. The company’s results will be released earlier that morning and made available on www.xpo.com. Access information:Call toll-free from US/Canada: 1-877-269-7756International callers: +1-201-689-7817Live webcast online at: www.xpo.com/investors A replay of the conference call will be available until August 31, 2024, by calling toll-free (from US/Canada) 1-877-660-6853; international callers dial +1-201-612-7415. Use the passcode 13747657. Additionally, the call will be archived on www.xpo.com/investors. About XPO XPO, Inc. (NYSE: XPO) is a leader in asset-based less-than-truckload (LTL) freight transportation in North America. The company’s customer-focused...

Continue reading

Saratoga Investment Corp. Announces Fiscal First Quarter 2025 Financial Results

NEW YORK, July 09, 2024 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE:SAR) (“Saratoga Investment” or “the Company”), a business development company (“BDC”), today announced financial results for its 2025 fiscal first quarter, with Net Investment Income (“NII”) per share of $1.05 versus $1.35 last year and $0.94 for last year’s fourth quarter, and adjusted NII per share of $1.05 versus $1.08 last year and $0.94 for last year’s fourth quarter. Saratoga Investment’s annualized first quarter dividend of $0.74 per share and adjusted net investment income of $1.05 per share imply a 13.1% dividend yield and 18.6% earnings yield based on its recent stock price of $22.59 per share on July 8, 2024. This substantial overearning of the dividend by 31c this quarter, or $1.24 annualized per share, amply supports the increased level of dividends,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.